-
CMS Estimates Savings for Patients from Medicare Inflation Rebates
26 Mar 2024 21:13 GMT
… for certain drugs. The Centers for Medicare & Medicaid Services intends … ): chemotherapy induced nausea; Helsinn
Argatroban (Accord) with HCPCS code …
Minocin (minocycline): infections; Torrent Pharmaceuticals
Nexterone (amiodarone) (Baxter): for …
-
Argatroban Combo Improves Functional Recovery in Stroke
18 Mar 2024 11:20 GMT
… or alteplase thrombolytic treatment in these patients … (three randomized controlled trials and eight retrospective cohort … 3%) received argatroban plus antiplatelet or alteplase treatment and 4636 … this treatment (control group).
The effects of argatroban on …
-
Efficacy of Adjunctive Therapies for Acute Ischemic Stroke Based on Phase 3 MOST Trial: Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS
26 Feb 2024 20:01 GMT
… argatroban, a direct thrombin inhibitor, and eptifibatide (Integrillin; Millennium Pharmaceuticals), an antiplatelet drug … 2 trials suggest … trial (NCT03735979) assessing argatroban or eptifibatide, findings showed that both treatments … McGovern Medical School …
-
Argatroban may Revolutionize Stroke Treatment, Offering Hope for Improved Outcomes
21 Jan 2024 13:05 GMT
… the landscape of stroke treatment.
The clinical trial, an open-label, blinded … to investigate whether incorporating argatroban into the treatment regimen could lead to … promising outcomes of this trial suggest that argatroban could play a crucial …
-
Argatroban Improves Early Neurological Deterioration Following Ischemic Stroke
13 Jan 2024 00:12 GMT
… the EASE clinical trial (NCT04275180) showed that treatment with argatroban and antiplatelet therapy … , Zhejang University School of medicine, the trial’s primary end point was … results of the EASE trial with results of trials of adjunctive parenteral …
-
Biden issues inflation penalties on these drugs
14 Dec 2023 20:39 GMT
… drugs including blood thinners, antibiotics and cancer medications administered at a doctor… five drugs. Those drugs include the blood thinner argatroban, the chemotherapy drug … that the pharmaceutical supply chain can deliver critical medicines to …
-
Triple drug-coated stent may reduce risk for stent thrombosis, target lesion failure
09 Nov 2023 16:36 GMT
… adjust medication in time for an urgent surgery.”
For the DESyne trial … triple-drug, site-specific antithrombotic therapy — two anticoagulants, rivaroxaban and argatroban, plus … BDS Plus triple drug-eluting coronary implant (Elixir Medical; n = 100) or …
-
TCT 2023: Six-Month Clinical Data from DESyne® BDS Plus Randomized Controlled Trial (RCT) Support Safety and Effectiveness of World’s First Site-Specific Antithrombotic Drug Therapy
25 Oct 2023 15:14 GMT
… three drugs: two anticoagulants (rivaroxaban and argatroban) and … treatment of de novo native coronary artery lesions. The trial … of Randomized Controlled Trials, Cardiovascular Quality and … Adherence with cardiovascular medications and the outcomes in …
-
Herbal medicine Market Trends and Forecast, 2023-2032
11 Oct 2023 13:33 GMT
… Segments :
By Product Type:
Medicinal Part
Medicine Function
Active Ingredient
By APPLICATION … Related Reports:
Herbal Medicines Market
Argatroban Market
Digital Medicine Market
About Us
Allied …
-
Argatroban Market: Growth, Challenges, and Competitive Landscape
04 Oct 2023 09:14 GMT
… (HIT) and thrombosis.
Medical Applications: Argatroban is primarily used in healthcare … to increased usage of Argatroban.
Competitive Landscape: Key pharmaceutical companies compete in … focus on improving the drug';s formulation and expanding …